{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:48:10Z","timestamp":1786992490954,"version":"build-2736575974"},"reference-count":73,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32-DK007066"],"award-info":[{"award-number":["T32-DK007066"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jhep.2020.11.014","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T11:24:49Z","timestamp":1605525889000},"page":"716-733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Hepatitis C viraemic organs in solid organ transplantation"],"prefix":"10.1016","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1506-232X","authenticated-orcid":false,"given":"Kelley","family":"Weinfurtner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Rajender","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2020.11.014_bib2","author":"Scholz"},{"issue":"11","key":"10.1016\/j.jhep.2020.11.014_bib3","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1111\/j.1600-6143.2010.03280.x","article-title":"Long-term experience with kidney transplantation from hepatitis C-positive donors into hepatitis C-positive recipients","volume":"10","author":"Morales","year":"2010","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.jhep.2020.11.014_bib4","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/TP.0000000000000479","article-title":"Shorter waitlist times and improved graft survivals are observed in patients who accept hepatitis C virus+ renal allografts","volume":"99","author":"Scalea","year":"2015","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.jhep.2020.11.014_bib5","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1432-2277.2010.01092.x","article-title":"Liver allografts from hepatitis C positive donors can offer good outcomes in hepatitis C positive recipients: a US National Transplant Registry analysis","volume":"23","author":"Northup","year":"2010","journal-title":"Transpl Int"},{"issue":"11","key":"10.1016\/j.jhep.2020.11.014_bib6","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/TP.0b013e318219eb8f","article-title":"Long-term follow-up and outcome of liver transplantation from anti-hepatitis C virus-positive donors: a European multicentric case-control study","volume":"91","author":"Ballarin","year":"2011","journal-title":"Transplantation"},{"issue":"15","key":"10.1016\/j.jhep.2020.11.014_bib7","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1001\/jama.296.15.1843","article-title":"Hepatitis C virus seropositivity in organ donors and survival in heart transplant recipients","volume":"296","author":"Gasink","year":"2006","journal-title":"J\u00a0Am Med Assoc"},{"issue":"2","key":"10.1016\/j.jhep.2020.11.014_bib8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jss.2011.10.028","article-title":"Elderly recipients of hepatitis C positive renal allografts can quickly develop liver disease","volume":"176","author":"Flohr","year":"2012","journal-title":"J\u00a0Surg Res"},{"issue":"2","key":"10.1016\/j.jhep.2020.11.014_bib9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.healun.2015.10.012","article-title":"Impact of donor and recipient hepatitis C status in lung transplantation","volume":"35","author":"Englum","year":"2016","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"10","key":"10.1016\/j.jhep.2020.11.014_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ctr.13055","article-title":"Long-term outcomes and transmission rates in hepatitis C virus-positive donor to hepatitis C virus-negative kidney transplant recipients: analysis of United States national data","volume":"31","author":"Gupta","year":"2017","journal-title":"Clin Transplant"},{"issue":"9","key":"10.1016\/j.jhep.2020.11.014_bib11","doi-asserted-by":"crossref","first-page":"637","DOI":"10.7326\/M16-2575","article-title":"Oral direct-acting agent therapy for hepatitis c virus infection: a systematic review","volume":"166","author":"Falade-Nwulia","year":"2017","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.jhep.2020.11.014_bib12","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1111\/ajt.13971","article-title":"Improving organ utilization to help overcome the tragedies of the opioid epidemic","volume":"16","author":"Goldberg","year":"2016","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.jhep.2020.11.014_bib13","doi-asserted-by":"crossref","first-page":"702","DOI":"10.7326\/M17-2451","article-title":"The drug overdose epidemic and deceased-donor transplantation in the United States: a national registry study","volume":"168","author":"Durand","year":"2018","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.jhep.2020.11.014_bib14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jhep.2018.03.007","article-title":"High SVR12 with 8-week and 12-week glecaprevir\/pibrentasvir therapy: an integrated analysis of HCV genotype 1\u20136 patients without cirrhosis","volume":"69","author":"Puoti","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.jhep.2020.11.014_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/tid.12972","article-title":"Safety and effectiveness of direct acting antivirals for treatment of hepatitis C virus in patients with solid organ transplantation","volume":"20","author":"Mansour","year":"2018","journal-title":"Transpl Infect Dis"},{"issue":"10003","key":"10.1016\/j.jhep.2020.11.014_bib16","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0140-6736(15)00349-9","article-title":"Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study","volume":"386","author":"Roth","year":"2015","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.jhep.2020.11.014_bib17","doi-asserted-by":"crossref","first-page":"2394-2395","DOI":"10.1056\/NEJMc1705221","article-title":"Trial of transplantation of HCV-infected kidneys into uninfected recipients","volume":"376","author":"Goldberg","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.jhep.2020.11.014_bib18","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1164\/rccm.201712-2614LE","article-title":"Lung transplantation from hepatitis C viremic donors to uninfected recipients","volume":"197","author":"Abdelbasit","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.jhep.2020.11.014_bib19","doi-asserted-by":"crossref","first-page":"523","DOI":"10.7326\/M17-2871","article-title":"Direct-acting antiviral prophylaxis in kidney transplantation from hepatitis C virus-infected donors to noninfected recipients an open-label nonrandomized trial","volume":"168","author":"Durand","year":"2018","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.jhep.2020.11.014_bib20","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/ajt.15162","article-title":"Liver transplantation for hepatitis C virus (HCV) non-viremic recipients with HCV viremic donors","volume":"19","author":"Kwong","year":"2018","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.jhep.2020.11.014_bib21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/M18-0749","article-title":"Twelve-month outcomes after transplant of hepatitis C\u2013infected kidneys into uninfected recipients a single-group trial","volume":"169","author":"Reese","year":"2018","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.jhep.2020.11.014_bib22","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.healun.2018.01.1293","article-title":"Early outcomes using hepatitis C\u2013positive donors for cardiac transplantation in the era of effective direct-acting anti-viral therapies","volume":"37","author":"Schlendorf","year":"2018","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"12","key":"10.1016\/j.jhep.2020.11.014_bib23","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.healun.2019.08.019","article-title":"Outcomes of heart transplantation from hepatitis C virus\u2013positive donors","volume":"38","author":"Aslam","year":"2019","journal-title":"J\u00a0Hear Lung Transpl [Internet]"},{"issue":"10","key":"10.1016\/j.jhep.2020.11.014_bib24","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S2468-1253(19)30240-7","article-title":"Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label study","volume":"4","author":"Bethea","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jhep.2020.11.014_bib25","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/ajt.15664","article-title":"Ultra-short duration direct acting antiviral prophylaxis to prevent virus transmission from hepatitis C viremic donors to hepatitis C negative kidney transplant recipients","volume":"20","author":"Gupta","year":"2019","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.jhep.2020.11.014_bib26","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1111\/ajt.15311","article-title":"Transplanting hepatitis C virus\u2013infected hearts into uninfected recipients: a single-arm trial","volume":"19","author":"McLean","year":"2019","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.jhep.2020.11.014_bib27","first-page":"1","article-title":"Hepatitis C donor viremic cardiac transplantation: a practical approach","volume":"34","author":"Morris","year":"2019","journal-title":"Clin Transplant"},{"issue":"2","key":"10.1016\/j.jhep.2020.11.014_bib28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamacardio.2019.4748","article-title":"Expanding heart transplant in the era of direct-acting antiviral therapy for hepatitis C","volume":"5","author":"Schlendorf","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"17","key":"10.1016\/j.jhep.2020.11.014_bib29","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJMoa1812406","article-title":"Heart and lung transplants from HCV infected donors to uninfected recipients","volume":"380","author":"Woolley","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.jhep.2020.11.014_bib30","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1111\/ajt.15768","article-title":"Immediate administration of antiviral therapy after transplantation of hepatitis C-infected livers into uninfected recipients: implications for therapeutic planning","volume":"20","author":"Bethea","year":"2020","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.jhep.2020.11.014_bib31","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S2213-2600(19)30268-1","article-title":"Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial","volume":"8","author":"Cypel","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jhep.2020.11.014_bib32","article-title":"Four-week direct-acting antiviral prophylaxis for kidney transplantation from hepatitis C-viremic donors to hepatitis C-negative recipients: an open-label nonrandomized study","author":"Durand","year":"2020","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.jhep.2020.11.014_bib33","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S2468-1253(20)30081-9","article-title":"Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label study","volume":"5","author":"Feld","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"May","key":"10.1016\/j.jhep.2020.11.014_bib34","first-page":"1","article-title":"The effect of pulsatile pump perfusion on hepatitis C transmission in kidney transplantation: a prospective pilot study","author":"Forbes","year":"2020","journal-title":"Clin Transplant"},{"issue":"1","key":"10.1016\/j.jhep.2020.11.014_bib35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.31011","article-title":"Hepatitis C virus NAT-positive solid organ allografts transplanted into hepatitis C virus\u2013negative recipients: a real-world experience","volume":"72","author":"Kapila","year":"2020","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.jhep.2020.11.014_bib36","doi-asserted-by":"crossref","first-page":"e13989","DOI":"10.1111\/ctr.13989","article-title":"Outcomes with treatment with glecaprevir\/pibrentasvir following heart transplantation Utilizing hepatitis C viremic donors","volume":"34","author":"Reyentovich","year":"2020","journal-title":"Clin Transplant"},{"issue":"11","key":"10.1016\/j.jhep.2020.11.014_bib37","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1681\/ASN.2020050686","article-title":"Multicenter study to transplant hepatitis C \u2013 infected kidneys ( MYTHIC ): an open-label study of combined glecaprevir and pibrentasvir to treat recipients of transplanted kidneys from deceased donors with Hepatitis C Virus Infect","volume":"31","author":"Sise","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jhep.2020.11.014_bib38","article-title":"Impact of early initiation of direct-acting antiviral therapy in thoracic organ transplantation from hepatitis C virus positive donors","author":"Smith","year":"2020","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"11","key":"10.1016\/j.jhep.2020.11.014_bib39","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1111\/ajt.14381","article-title":"The American Society of Transplantation Consensus Conference on the use of hepatitis C viremic donors in solid organ transplantation","volume":"17","author":"Levitsky","year":"2017","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.jhep.2020.11.014_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2893.2011.01548.x","article-title":"Immunosuppression, liver injury and post-transplant HCV recurrence","volume":"19","author":"Ciesek","year":"2012","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jhep.2020.11.014_bib41","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/lt.23559","article-title":"Cholestatic hepatitis C following liver transplantation: an outcome-based histological definition, clinical predictors, and prognosis","volume":"19","author":"Verna","year":"2013","journal-title":"Liver Transpl"},{"issue":"5 I","key":"10.1016\/j.jhep.2020.11.014_bib42","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/hep.1840360705","article-title":"The burden of hepatitis C in the United States","volume":"36","author":"Kim","year":"2002","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jhep.2020.11.014_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/jhep.2002.34613","article-title":"Hepatitis C infection and the patient with end-stage renal disease","volume":"36","author":"Fabrizi","year":"2002","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jhep.2020.11.014_bib44","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/j.1600-6143.2010.03091.x","article-title":"Underutilization of hepatitis C-positive kidneys for hepatitis c-positive recipients","volume":"10","author":"Kucirka","year":"2010","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.jhep.2020.11.014_bib45","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1056\/NEJMp1505074","article-title":"Transplanting hepatitis C\u2013positive kidneys","volume":"373","author":"Reese","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.jhep.2020.11.014_bib46","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/ajt.13976","article-title":"Changes in utilization and discard of hepatitis C\u2013infected donor livers in the recent era","volume":"17","author":"Bowring","year":"2017","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1016\/j.jhep.2020.11.014_bib47","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1111\/ajt.14386","article-title":"Utilization of organs from donors according to hepatitis C antibody and nucleic acid testing status: time for change","volume":"17","author":"Kling","year":"2017","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.jhep.2020.11.014_bib48","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1053\/j.gastro.2017.01.003","article-title":"Changes in the prevalence of hepatitis C virus infection, nonalcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the waitlist for liver transplantation","volume":"152","author":"Goldberg","year":"2017","journal-title":"Gastroenterology"},{"issue":"s1","key":"10.1016\/j.jhep.2020.11.014_bib49","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/ajt.15672","article-title":"OPTN\/SRTR 2018 Annual data report: kidney","volume":"20","author":"Hart","year":"2020","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.jhep.2020.11.014_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/tid.13204","article-title":"Trends in utilization of deceased donor kidneys based on hepatitis C virus status and impact of public health service labeling on discard","volume":"22","author":"Ariyamuthu","year":"2020","journal-title":"Transpl Infect Dis"},{"issue":"s1","key":"10.1016\/j.jhep.2020.11.014_bib51","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/ajt.15674","article-title":"OPTN\/SRTR 2018 Annual data report: liver","volume":"20","author":"Kwong","year":"2020","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.jhep.2020.11.014_bib52","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.cgh.2018.09.036","article-title":"Increasing trends in transplantation of HCV\u2013positive livers into uninfected recipients","volume":"17","author":"Cholankeril","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.11.014_bib53","article-title":"Liver transplantation of HCV-viremic donors into HCV-negative recipients in the USA: increasing frequency with profound geographic variation","author":"Cotter","year":"2020","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.jhep.2020.11.014_bib54","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.healun.2019.06.023","article-title":"Utilization rates and clinical outcomes of hepatitis C positive donor hearts in the contemporary era","volume":"38","author":"Madan","year":"2019","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"March","key":"10.1016\/j.jhep.2020.11.014_bib55","first-page":"1","article-title":"Local and regional variability in utilization and allocation of hepatitis C virus\u2013infected hearts for transplantation","author":"Prakash","year":"2020","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.jhep.2020.11.014_bib56","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.kint.2018.02.016","article-title":"Factors leading to the discard of deceased donor kidneys in the United States","volume":"94","author":"Mohan","year":"2018","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.jhep.2020.11.014_bib57","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1111\/ajt.15496","article-title":"Short-term outcomes of deceased donor renal transplants of HCV uninfected recipients from HCV seropositive nonviremic donors and viremic donors in the era of direct-acting antivirals","volume":"19","author":"La Hoz","year":"2019","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.jhep.2020.11.014_bib58","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/hep.29704","article-title":"Hepatitis C transmission from seropositive, nonviremic donors to non\u2013hepatitis C liver transplant recipients","volume":"67","author":"Bari","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jhep.2020.11.014_bib59","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jamcollsurg.2018.12.004","article-title":"Use of hepatitis C virus antibody-positive donor livers in hepatitis C nonviremic liver transplant recipients","volume":"228","author":"Luckett","year":"2019","journal-title":"J\u00a0Am Coll Surg"},{"issue":"12","key":"10.1016\/j.jhep.2020.11.014_bib60","doi-asserted-by":"crossref","first-page":"e005276","DOI":"10.1161\/CIRCHEARTFAILURE.118.005276","article-title":"Current use of hearts from hepatitis C viremic donors","volume":"11","author":"Moayedi","year":"2018","journal-title":"Circ Heart Fail"},{"issue":"2","key":"10.1016\/j.jhep.2020.11.014_bib61","doi-asserted-by":"crossref","first-page":"e014495","DOI":"10.1161\/JAHA.119.014495","article-title":"Outcomes of adult heart transplantation using hepatitis C\u2013positive donors","volume":"9","author":"Kilic","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"10","key":"10.1016\/j.jhep.2020.11.014_bib62","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1681\/ASN.2019050462","article-title":"National trends in utilization and 1-year outcomes with transplantation of HCV-viremic kidneys","volume":"30","author":"Potluri","year":"2019","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jhep.2020.11.014_bib63","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/lt.20849","article-title":"Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts","volume":"12","author":"Khapra","year":"2006","journal-title":"Liver Transpl"},{"issue":"11","key":"10.1016\/j.jhep.2020.11.014_bib64","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1111\/ajt.14447","article-title":"HCV viremic donors with hepatic bridging fibrosis: are we ready to use their livers in the era of direct-acting antivirals?","volume":"17","author":"Martini","year":"2017","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.jhep.2020.11.014_bib65","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jhep.2016.07.042","article-title":"Global genotype distribution of hepatitis C viral infection among people who inject drugs","volume":"65","author":"Robaeys","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2020.11.014_bib66","doi-asserted-by":"crossref","first-page":"214","DOI":"10.7326\/M17-3088","article-title":"Transplanting hepatitis C virus\u2013infected versus uninfected kidneys into hepatitis C virus\u2013infected recipients: a cost-effectiveness analysis","volume":"169","author":"Eckman","year":"2018","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.jhep.2020.11.014_bib67","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1111\/liv.13878","article-title":"Delisting HCV-infected liver transplant candidates who improved after viral eradication: outcome 2 years after delisting","volume":"38","author":"Perricone","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2020.11.014_bib68","article-title":"In the era of direct-acting antivirals, liver transplant delisting due to clinical improvement for hepatitis C remains infrequent","author":"Bittermann","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.jhep.2020.11.014_bib69","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1053\/j.gastro.2018.03.022","article-title":"Baseline factors associated with improvements in decompensated cirrhosis after direct-acting antiviral therapy for hepatitis C virus infection","volume":"154","author":"El-Sherif","year":"2018","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jhep.2020.11.014_bib70","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jhep.2020.03.031","article-title":"DAA therapy and long-term hepatic function in advanced\/decompensated cirrhosis: real-world experience from HCV-TARGET cohort","volume":"73","author":"Verna","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2020.11.014_bib71","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1097\/TP.0000000000001990","article-title":"Liver volume as a predictor of functional improvement post-DAA treatment","volume":"102","author":"Di Maira","year":"2018","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.jhep.2020.11.014_bib72","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/jvh.12877","article-title":"The optimal timing of hepatitis C therapy in liver transplant-eligible patients: cost-effectiveness analysis of new opportunities","volume":"25","author":"Cortesi","year":"2018","journal-title":"J\u00a0Viral Hepat"},{"issue":"10","key":"10.1016\/j.jhep.2020.11.014_bib73","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1111\/ajt.14929","article-title":"Cost-effectiveness of using kidneys from hepatitis C nucleic acid test\u2013positive donors for transplantation in hepatitis C\u2013negative recipients","volume":"18","author":"Kadatz","year":"2018","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.jhep.2020.11.014_bib74","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1053\/j.ajkd.2019.11.005","article-title":"Cost-effectiveness of using kidneys from HCV-viremic donors for transplantation into HCV-uninfected recipients","volume":"75","author":"Eckman","year":"2020","journal-title":"Am J Kidney Dis"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820337673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820337673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:42:38Z","timestamp":1759174958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827820337673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0168827820337673"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2020.11.014","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C viraemic organs in solid organ transplantation","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2020.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}